Stage-Specific Transcriptome Landscape of Hepatocellular Carcinoma: Insights From Super and Poor Survivors With Prognostic Signature Identification

  • 0National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

|

|

Summary

This summary is machine-generated.

A novel 19-gene signature accurately predicts survival in hepatocellular carcinoma (HCC) patients by analyzing transcriptomic differences between super and poor survivors. This signature aids in personalized prognosis for HCC.

Area Of Science

  • Oncology
  • Genomics
  • Transcriptomics

Background

  • Hepatocellular carcinoma (HCC) prognosis varies widely, even within the same clinical stage.
  • Identifying molecular markers for patient survival is crucial for personalized treatment.

Purpose Of The Study

  • To characterize the stage-specific transcriptomic landscape in HCC super survivors.
  • To develop a prognostic gene signature for predicting HCC patient survival.

Main Methods

  • Analysis of The Cancer Genome Atlas (TCGA) data from HCC patients.
  • Gene set enrichment analysis stratified by tumor stage.
  • Development and validation of a 19-gene signature using TCGA and International Cancer Genome Consortium (ICGC) cohorts.

Main Results

  • Stage-specific transcriptomic differences were observed in immune response, catabolic activities, and glycolysis.
  • Super survivors exhibited less active cell cycle processes across all stages.
  • The 19-gene signature achieved 90.8% accuracy in distinguishing super from poor survivors and showed reliable survival prediction in validation cohorts.

Conclusions

  • A 19-gene signature, reflecting dynamic shifts during HCC progression, can accurately predict patient survival.
  • This signature holds potential as a tool for personalized prognosis in HCC.